Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Begins Recruitment Of Part-Time Sales Reps

This article was originally published in The Pink Sheet Daily

Executive Summary

Wyeth will begin to implement its plan to integrate part-time employees into its U.S. primary care sales force starting in late November

You may also be interested in...



Wyeth Pharmaceuticals U.S. President Geno Germano: An Interview With “The Pink Sheet” DAILY

Exec discusses Wyeth's selling model and how the firm is planning for potential launches this year of products like Pristiq and Torisel.

Wyeth Pharmaceuticals U.S. President Geno Germano: An Interview With “The Pink Sheet” DAILY

Exec discusses Wyeth's selling model and how the firm is planning for potential launches this year of products like Pristiq and Torisel.

Wyeth Cuts European Primary Care Sales Force By 25%

Despite reductions, Wyeth said it has strengthened specialty sales efforts around products like Enbrel.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061143

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel